Inclusion of renal vascular lesions in the 2003 ISN/RPS system for classifying lupus nephritis improves renal outcome predictions

D’Agati, 2007, Renal disease in systemic lupus erythematosus, mixed connective tissue disease, Sjogren's syndrome, and rheumatoid arthritis, 517 Appel, 2008, Secondary glomerular disease, 1067 Banfi, 1991, Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL), Am J Kidney Dis, 18, 240, 10.1016/S0272-6386(12)80885-7 Appel, 1994, Renal vascular complications of systemic lupus erythematosus, J Am Soc Nephrol, 4, 1499, 10.1681/ASN.V481499 McCluskey, 1975 Churg, 1982 Churg, 1995 Muenz, 1984, Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome, Kidney Int, 25, 689, 10.1038/ki.1984.75 Weening, 2004, The classification of glomerulonephritis in systemic lupus erythematosus revisited, Kidney Int, 65, 521, 10.1111/j.1523-1755.2004.00443.x Cervera, 2006, Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the ‘Euro-Lupus Project’, Autoimmun Rev, 5, 180, 10.1016/j.autrev.2005.06.004 Cervera, 2006, European Working Party on Systemic Lupus Erythematosus: a 15-year report, Autoimmun Rev, 5, 549, 10.1016/j.autrev.2006.02.015 Grishman, 1988, Vascular lesions in lupus nephritis, Mod Pathol, 1, 235 Appel, 1978, Renal involvement in systemic lupus erythematosus (SLE): a study of 56 patients emphasizing histologic classification, Medicine (Baltimore), 57, 371, 10.1097/00005792-197809000-00001 Appel, 1987, Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization, Am J Med, 83, 877, 10.1016/0002-9343(87)90645-0 Trouw, 2004, Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes, J Clin Invest, 114, 679, 10.1172/JCI200421075 Porta, 1999, Thrombotic thrombocytopenic purpura and autoimmunity: a tale of shadows and suspects, Haematologica, 84, 260 Vasoo, 2002, Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: disease activity and the use of cytotoxic drugs, Lupus, 11, 443, 10.1191/0961203302lu224oa Letchumanan, 2009, A comparison of thrombotic thrombocytopenic purpura in an inception cohort of patients with and without systemic lupus erythematosus, Rheumatology (Oxford), 48, 399, 10.1093/rheumatology/ken510 Silvarino, 2011, Nephropathy associated with antiphospholipid antibodies in patients with systemic lupus erythematosus, Lupus, 20, 721, 10.1177/0961203310397410 Zheng, 2009, Antiphospholipid antibody profiles in lupus nephritis with glomerular microthrombosis: a prospective study of 124 cases, Arthritis Res Ther, 11, R93, 10.1186/ar2736 Cohen, 2008, Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis, Arthritis Rheum, 58, 2460, 10.1002/art.23662 Shen, 2010, Association between anti-beta2 glycoprotein I antibodies and renal glomerular C4d deposition in lupus nephritis patients with glomerular microthrombosis: a prospective study of 155 cases, Lupus, 19, 1195, 10.1177/0961203310368409 Baldwin, 1977, Lupus nephritis. Clinical course as related to morphologic forms and their transitions, Am J Med, 62, 12, 10.1016/0002-9343(77)90345-X Tsumagari, 1985, Incidence and significance of intrarenal vasculopathies in patients with systemic lupus erythematosus, Hum Pathol, 16, 43, 10.1016/S0046-8177(85)80212-4 Abdellatif, 2010, True vasculitis in lupus nephritis, Clin Nephrol, 74, 106, 10.5414/CNP74106 Urowitz, 1976, The bimodal mortality pattern of systemic lupus erythematosus, Am J Med, 60, 221, 10.1016/0002-9343(76)90431-9 Roman, 2003, Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus, N Engl J Med, 349, 2399, 10.1056/NEJMoa035471 Thacker, 2010, The detrimental effects of IFN-alpha on vasculogenesis in lupus are mediated byrepression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction, J Immunol, 185, 4457, 10.4049/jimmunol.1001782 Clancy, 2010, Endothelial function and its implications for cardiovascular and renal disease in systemic lupus erythematosus, Rheum Dis Clin North Am, 36, 145, 10.1016/j.rdc.2009.12.011 Lewis, 2012, Combining lupus and hyperlipidaemia in mice reveals distinct roles for complement in glomerulonephritis and atherosclerosis Austin, 1994, Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data, Kidney Int, 45, 544, 10.1038/ki.1994.70 Korbet, 2000, Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group, Am J Kidney Dis, 35, 904, 10.1016/S0272-6386(00)70262-9 Hiramatsu, 2008, Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions, Rheumatology (Oxford), 47, 702, 10.1093/rheumatology/ken019 Hochberg, 1997, Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum, 40, 1725, 10.1002/art.1780400928 Descombes, 1997, Renal vascular lesions in lupus nephritis, Medicine (Baltimore), 76, 355, 10.1097/00005792-199709000-00003 Roberts, 2009, The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility, Kidney Int, 76, 546, 10.1038/ki.2009.168 Wang, 2007, Induction therapies for class IV lupus nephritis with non-inflammatory necrotizing vasculopathy: mycophenolate mofetil or intravenous cyclophosphamide, Lupus, 16, 707, 10.1177/0961203307081340 Ginzler, 2005, Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis, N Engl J Med, 353, 2219, 10.1056/NEJMoa043731 Chan, 2005, Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprine, Lupus, 14, 265, 10.1191/0961203305lu2081oa Wang, 2008, Induction treatment of proliferative lupus nephritis with leflunomide combined with prednisone: a prospective multi-centre observational study, Lupus, 17, 638, 10.1177/0961203308089408 Yu, 2009, Clinicopathological characteristics and outcomes of patients with crescentic lupus nephritis, Kidney Int, 76, 307, 10.1038/ki.2009.136